Skip to main content

Company Filings

SEC Emblem
U.S. Securities and
Exchange Commission
  • About
    • Careers
    • Commissioners
    • Contact
    • Reports and Publications
    • Securities Laws
    • Mission
  • Divisions & Offices
    • Corporation Finance
    • Enforcement
    • Investment Management
    • Economic and Risk Analysis
    • Trading and Markets
    • Office of Administrative Law Judges
    • Examinations
    • Regional Offices
  • Enforcement
    • Litigation Releases
    • Administrative Proceedings
    • Opinions and Adjudicatory Orders
    • Accounting and Auditing
    • Trading Suspensions
    • How Investigations Work
    • Receiverships
    • Information for Harmed Investors
  • Regulation
    • Rulemaking Activity
    • Proposed Rules
    • Final Rules
    • Interim Final Temporary Rules
    • Other Orders and Notices
    • Self-Regulatory Organizations
    • Staff Interpretations
  • Education
    • Investor Education
    • Glossaries
    • Small Business Capital Raising
  • Filings
    • EDGAR – Search & Access
    • EDGAR – Information for Filers
    • Company Filing Search
    • How to Search EDGAR
    • Forms List
    • About EDGAR
  • News
    • Press Releases
    • Speeches and Statements
    • Securities Topics
    • Upcoming Events
    • Webcasts
    • SEC in the News
    • SEC Videos
    • Media Gallery
  • U.S. Securities and Exchange Commission
    • Divisions & Offices
    • Enforcement
    • Regulation
    • Education
    • Filings
    • Newsroom
  • Newsroom
    • Press Releases
    • Testimony
  • RSS Feeds
    • Press Releases
    • Public Statements
    • Speeches
    • Testimony
  • About the SEC
  • Advisory Committees
  • Commissioners
  • Contact
  • Diversity and Inclusion
  • Division and Office Directors
  • Divisions and Offices
  • Forms
  • Privacy and Security
  • Regional Offices
  • Reports and Publications
  • SEC and Markets Data
  • Securities Laws
  • Upcoming Events
  • Mission

Other

Five Prime Therapeutics, Inc.

Dec. 12, 2017

Downloads

pdf
18-00253-t.pdf (436.22 KB)
Modified: July 21, 2022

STAY CONNECTED
1 Twitter 2 Facebook 3RSS 4YouTube
6LinkedIn 8 Email Updates

About The SEC

  • Budget & Performance
  • Careers
  • Commission Votes
  • Contact
  • Contracts
  • Data Resources

Transparency

  • Accessibility & Disability
  • Diversity & Inclusion
  • FOIA
  • Inspector General
  • No FEAR Act & EEO Data
  • Ombuds
  • Whistleblower Protection

Websites

  • Investor.gov
  • Related Sites
  • USA.gov

Site Information

  • Plain Writing
  • Privacy & Security
  • Site Map
Return to Top